Generic Injectables Market Size, Growth, Analysis, Outlook, Forecast 2024-2032 menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
The purchase will give a boost to Bristol as patent expirations weigh on sales of its oncology medicines. The company had to slash its revenue outlook this year after sales of blood cancer drug Revlimid, its third-largest revenue driver, withered in the face of generic rivals. Its top-selling blood thinner Eliquis and cancer immunotherapy blockbuster Opdivo are also scheduled to face competition from generics later this decade.